date:Apr 22, 2013
South Africa's Aspen Pharmacare has entered into an agreement to acquire Nestl's infant nutrition businesses in Australia and South Africa for a total purchase consideration of $215m.
The acquisition includes certain rights to intellectual property licences, shares and net assets in the IN businesses - Australian IN business and Southern African IN business, which are currently conducted by Pfizer.
The Australian IN business distributes a portfolio of IN products in Australia, while the Southe